Asia Pacific Esoteric Testing Market Size By Test type (Endocrinology, Infectious Disease & Immunology, Oncology, Toxicology, Neurology, Genomics), By Technology (Mass Spectrometry, Flow Cytometry, ELISA, Radioimmunoassay, Chemiluminescence, RT-PCR), Industry Analysis Report, Regional Outlook (Japan, China, India, Australia, Korea, Singapore, Malaysia), Application Potential, Competitive Market Share & Forecast, 2019 - 2025

Published Date: May 2019 | Publisher: Graphical Research Report ID: GR1169 | Delivery : PDF

Asia Pacific Esoteric Testing Market size was valued at USD 5.0 billion in 2018 and is expected to witness 11.7% CAGR from 2019 to 2025.

China Esoteric Testing Market, By Technology, 2018 & 2025 (USD Mn)

China Esoteric Testing Market, By Technology, 2018 & 2025 (USD Mn)

Get more details on this report - Request Free Sample PDF  

 

Growing incidence of rare diseases will highly impact Asia Pacific esoteric testing industry growth in the upcoming years. As per the Ministry of Health and Family Welfare, around 72-96 million of Indians are affected by rare diseases. Thus, growing epidemiology of such diseases should increase the need for esoteric testing, thereby impelling the demand for esoteric testing in Asia Pacific over the upcoming period.

Increasing research and development regarding rare diseases should stimulate Asia Pacific esoteric testing industry growth. For instance, the Initiative on Rare and Undiagnosed Disease (IRUD) has collaborated technology and expertise to develop an approach for supporting patients with rare ailment. The initiative supports rare disease diagnosis that is difficult to detect. Such activities will impel Asia Pacific esoteric testing industry growth in the forecast period.

Growing demand for genetic testing owing to rising prevalence of genetic diseases will boost Asia Pacific esoteric testing market size in the forthcoming years. Changing lifestyle habits as well as rising exposure to harmful environmental factors will largely impact incidence of genetic disorders, thereby accelerating the adoption of esoteric testing. However, lack of skilled professionals may impede Asia Pacific esoteric testing market growth to a certain extent.

Neurology esoteric testing was valued at around USD 371 million in 2018. Growing occurrence of rare neurological disorders in young population will escalate the demand for neurological esoteric testing. Increasing advancements in detection of several rare neurological conditions will further aid in neoruology esoteric testing segmental growth in the coming years.   

Flow cytometry esoteric testing market is estimated to progress at more than 11.0% CAGR during the forecast years. Wide array of applications of flow cytometry in molecular testing including hematology tetsing, prenatal diagnosis, tumour immunology, genetic testing and others will elevate technology adoption. This technology is being extensively used for research purposes as well as offers reliable and accurate results, thus positively impacting growth of flow cytometry for esoteric testing in the foreseeable future.

Flow cytometry esoteric testing market is estimated to progress at more than 11.0% CAGR during the forecast years. Wide array of applications of flow cytometry in molecular testing including hematology tetsing, prenatal diagnosis, tumour immunology, genetic testing and others will elevate technology adoption. This technology is being extensively used for research purposes as well as offers reliable and accurate results, thus positively impacting growth of flow cytometry for esoteric testing in the foreseeable future.

Few of the key industry players competing in Asia Pacific esoteric testing industry involve Quest Diagnostics, Laboratory Corporation of America, Opko Health and Myriad Genetics. Companies are undertaking acquisitions and expansion strategies to fortify their business portfolio and expand geographical presence. For instance, in November 2018, Japan Clinical Laboratories, Inc. (a subsidiary of Miraca Holdings, Inc.) established a new pathology and cytology center. This new establishment is aimed at strengthening its presence in Japan’s Kansai region.

Rising occurrence of rare diseases resulted into the development of esoteric testing, thus marking the commencement of esoteric testing industry. Initially, polymerase chain reaction technology was adopted for detection of HIV disease and labelled as an esoteric test, which is now commonly equipped throughout the world. However, due to rise in prevalence of HIV, PCR test for HIV disease is no longer considered as an esoteric test. During the recent years, numerous laboratories and companies across Asia Pacific are undertaking strategic alliances with each other and healthcare facilities such as hospitals to conduct niche tests that are not cost-effective to such facilities. In the future years, increasing incidence of rare diseases will provide increased affordability for esoteric testing, thereby augmenting Asia Pacific esoteric testing industry growth over the forecast period.

Select License

Asia Pacific Esoteric Testing Market Trends Analysis Report 2025


Related Reports

Asia Pacific Bioreactors Market Share Analysis | Report 2019-25

Europe Bioreactors Market Share, Size Analysis | Report 2019-24

North America Bioreactors Market Share | Analysis Report 2019-2025

Healthcare 3D Printing – Asia Pacific Market Size Report 2018 - 2024

Why Choose us?
Share Social-media